![JCM | Free Full-Text | Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer JCM | Free Full-Text | Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer](https://pub.mdpi-res.com/jcm/jcm-08-02180/article_deploy/html/images/jcm-08-02180-ag.png?1577705982)
JCM | Free Full-Text | Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer
![A novel quantitative PCR of proliferation markers (Ki-67, topoisomerase IIα, and TPX2): an immunohistochemical correlation, testing, and optimizing for mantle cell lymphoma | SpringerLink A novel quantitative PCR of proliferation markers (Ki-67, topoisomerase IIα, and TPX2): an immunohistochemical correlation, testing, and optimizing for mantle cell lymphoma | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00428-010-0922-8/MediaObjects/428_2010_922_Fig1_HTML.gif)
A novel quantitative PCR of proliferation markers (Ki-67, topoisomerase IIα, and TPX2): an immunohistochemical correlation, testing, and optimizing for mantle cell lymphoma | SpringerLink
![Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer | BMC Cancer | Full Text Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-017-3111-1/MediaObjects/12885_2017_3111_Fig4_HTML.gif)
Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer | BMC Cancer | Full Text
![Analysis of proliferation markers in PDX and prognostic value of PLK1... | Download Scientific Diagram Analysis of proliferation markers in PDX and prognostic value of PLK1... | Download Scientific Diagram](https://www.researchgate.net/publication/343632959/figure/fig3/AS:932567456956417@1599352816801/Analysis-of-proliferation-markers-in-PDX-and-prognostic-value-of-PLK1-expression-in-early.png)
Analysis of proliferation markers in PDX and prognostic value of PLK1... | Download Scientific Diagram
![CDF decreased the expression of cell proliferation marker Ki-67, and other markers of tumor aggressiveness such as HIF-1α, VEGF, EZH2, EpCAM as well as the expression of HIF-1α, VEGF, IL-6, EZH2, Nanog, CDF decreased the expression of cell proliferation marker Ki-67, and other markers of tumor aggressiveness such as HIF-1α, VEGF, EZH2, EpCAM as well as the expression of HIF-1α, VEGF, IL-6, EZH2, Nanog,](https://s3-eu-west-1.amazonaws.com/ppreviews-plos-725668748/526339/preview.jpg)
CDF decreased the expression of cell proliferation marker Ki-67, and other markers of tumor aggressiveness such as HIF-1α, VEGF, EZH2, EpCAM as well as the expression of HIF-1α, VEGF, IL-6, EZH2, Nanog,
![Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study | British Journal of Cancer Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-020-0815-9/MediaObjects/41416_2020_815_Fig1_HTML.png)
Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study | British Journal of Cancer
![Human MKI67 (marker of proliferation Ki-67) mRNA specific transcripts levels evaluated by quantitative RT-PCR. Human MKI67 (marker of proliferation Ki-67) mRNA specific transcripts levels evaluated by quantitative RT-PCR.](https://s3-eu-west-1.amazonaws.com/ppreviews-plos-725668748/2258477/preview.jpg)
Human MKI67 (marker of proliferation Ki-67) mRNA specific transcripts levels evaluated by quantitative RT-PCR.
![Expression of stem cell markers and proliferation marker Ki67 in BTSCs... | Download Scientific Diagram Expression of stem cell markers and proliferation marker Ki67 in BTSCs... | Download Scientific Diagram](https://www.researchgate.net/publication/41429780/figure/fig1/AS:601605372141568@1520445306013/Expression-of-stem-cell-markers-and-proliferation-marker-Ki67-in-BTSCs-before-and-after.png)
Expression of stem cell markers and proliferation marker Ki67 in BTSCs... | Download Scientific Diagram
![Expression of proliferative markers cyclin D1 and Ki67 in epithelial... | Download Scientific Diagram Expression of proliferative markers cyclin D1 and Ki67 in epithelial... | Download Scientific Diagram](https://www.researchgate.net/publication/330133061/figure/fig2/AS:711211922501634@1546577544983/Expression-of-proliferative-markers-cyclin-D1-and-Ki67-in-epithelial-cells-of-cone-and.png)
Expression of proliferative markers cyclin D1 and Ki67 in epithelial... | Download Scientific Diagram
![Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis | Breast Cancer Research | Full Text Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis | Breast Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr2834/MediaObjects/13058_2010_9467_Fig2_HTML.jpg)